Form 4: Intuitive Surgical EVP Myriam Curet Reports Stock Transactions

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports the vesting and sale of restricted stock units (RSUs) and common stock transactions.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, filed a Form 4 detailing changes in beneficial ownership.
• On February 26, 2025, Curet vested 1,710 and 3,053 shares of common stock from Restricted Stock Units (RSUs).
• Also on February 26, 2025, Curet disposed of 848 and 1,514 shares of common stock to cover tax withholding at a price of $573.74.
• On February 27, 2025, Curet sold 2,401 shares of common stock at a price of $581.
• Following these transactions, Curet directly owns 353 shares of Intuitive Surgical common stock.
• Curet also acquired 1,602 new Restricted Stock Units that vest 100% on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: The document reflects routine stock transactions by an executive. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The reporting person acquired 1,602 new RSUs, indicating continued investment in the company's future.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedule of the RSUs suggests a continued long-term incentive for the reporting person.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be driven by various factors, including vesting schedules, personal financial planning, and diversification strategies. Monitoring these transactions can provide insights into executive sentiment and alignment with shareholder interests.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Vesting schedules, like the ones described in the document (25% per year over four years or 33% per year over three years), are standard practice in the industry.
• Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates